Role of interleukin-6 in a patient with tumor necrosis factor receptor-associated periodic syndrome: assessment of outcomes following treatment with the anti-interleukin-6 receptor monoclonal antibody tocilizumab
Lane T, Loeffler JM, Rowczenio DM, Gilbertson JA, Bybee A, Russell TL, Gillmore JD, Wechalekar AD, Hawkins PN, Lachmann HJ
Arthritis Rheum · 2011
Grade Dcase reportn=1
Key Findings
- ●First case report of tocilizumab in TRAPS
- ●Effective when etanercept and anakinra had failed
- ●Supports role of IL-6 in TRAPS pathogenesis
Referenced in (1 disease)
ID: pmid-21225679DOI: 10.1002/art.30161PMID: 21225679